VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+15.01%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$115M
AUM Growth
+$115M
(+45%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
28.25%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
267
New
23
Increased
109
Reduced
60
Closed
21
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.4M |
| 2 |
Geron
GERN
|
$870K |
| 3 |
Iovance Biotherapeutics
IOVA
|
$856K |
| 4 |
iShares MSCI India ETF
INDA
|
$838K |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$759K |
Top Sells
| 1 |
ProShares Ultra Utilities
UPW
|
$1.12M |
| 2 |
Vanguard Energy ETF
VDE
|
$721K |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$612K |
| 4 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
$421K |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$359K |
Sector Composition
| 1 | Healthcare | 78.8% |
| 2 | Financials | 0.81% |
| 3 | Technology | 0.52% |
| 4 | Consumer Discretionary | 0.44% |
| 5 | Communication Services | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTLA
101
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $627K | 0.54% |
19,203
-1,115
| -5% | -$36.4K |
|
102
Corbus Pharmaceuticals
CRBP
$121M
| $625K | 0.54% |
3,416
+1,835
| +116% | +$336K |
|
103
Puma Biotechnology
PBYI
$258M
| $621K | 0.54% |
9,129
-532
| -6% | -$36.2K |
|
|
FPRX
104
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $621K | 0.54% |
36,128
+18,757
| +108% | +$322K |
|
|
RETA
105
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $617K | 0.54% |
30,088
+16,171
| +116% | +$332K |
|
106
Celldex Therapeutics
CLDX
$1.57B
| $597K | 0.52% |
17,095
+9,164
| +116% | +$320K |
|
107
Seres Therapeutics
MCRB
$162M
| $563K | 0.49% |
3,836
+2,071
| +117% | +$304K |
|
|
CALA
108
DELISTED
Calithera Biosciences, Inc
CALA
| $559K | 0.49% |
4,436
+2,353
| +113% | +$297K |
|
|
PRTK
109
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $556K | 0.48% |
42,733
+23,153
| +118% | +$301K |
|
110
Insmed
INSM
$30.3B
| $550K | 0.48% |
24,409
+12,915
| +112% | +$291K |
|
111
Omeros
OMER
$284M
| $528K | 0.46% |
47,276
-2,789
| -6% | -$31.1K |
|
112
Akebia Therapeutics
AKBA
$827M
| $481K | 0.42% |
50,462
+27,003
| +115% | +$257K |
|
|
TTPH
113
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $402K | 0.35% |
6,546
+3,564
| +120% | +$219K |
|
|
MLNT
114
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $363K | 0.32% |
9,806
+5,395
| +122% | +$200K |
|
|
MRNS
115
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $307K | 0.27% |
20,097
+10,646
| +113% | +$163K |
|
116
Alibaba
BABA
$325B
| $212K | 0.18% |
1,153
+389
| +51% | +$71.5K |
|
|
SIOX
117
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $184K | 0.16% |
17,296
+9,010
| +109% | +$95.9K |
|
118
Itaú Unibanco
ITUB
$74.8B
| $171K | 0.15% |
21,896
+488
| +2% | +$3.81K |
|
119
HDFC Bank
HDB
$181B
| $153K | 0.13% |
3,094
+1,928
| +165% | +$95.3K |
|
120
America Movil
AMX
$58.9B
| $150K | 0.13% |
7,841
+1,497
| +24% | +$28.6K |
|
121
Ambev
ABEV
$33.5B
| $113K | 0.1% |
15,484
+893
| +6% | +$6.52K |
|
122
Fomento Económico Mexicano
FMX
$29B
| $104K | 0.09% |
1,133
+281
| +33% | +$25.8K |
|
123
Sociedad Química y Minera de Chile
SQM
$12.5B
| $103K | 0.09% |
+2,101
| New | +$103K |
|
124
Petrobras Class A
PBR.A
$73.4B
| $92K | 0.08% |
7,099
+102
| +1% | +$1.32K |
|
125
JD.com
JD
$44.2B
| $64K | 0.06% |
1,580
+428
| +37% | +$17.3K |
|